Trexo Robotics

Trexo Robotics operates at the intersection of pediatric mobility, rehabilitation, medical devices, and robotics. Its products include Trexo Home for use in the home, Trexo Plus for therapists and clinical settings, and Trexo Theo, a pediatric robotic exoskeleton. The company’s focus on children with disabilities and supported over-ground walking distinguishes its stated use case from general-purpose mobility hardware and rehabilitation equipment designed for broader patient populations. The September 2026 announcement described Trexo Theo as cleared for home use in the United States, while the January 2026 adoption of Trexo Plus at McMaster Children’s Hospital provides a specific example of clinical deployment. The wider field includes mobility aids and rehabilitation systems, but Trexo’s stated emphasis is active, repetitive walking with a wearable robotic device, including use beyond clinics. Its small reported employee range and limited funding disclosure suggest it remains a relatively small specialist rather than a scaled medical-device incumbent. Its competitive position will depend on evidence of patient outcomes, affordability, access, and repeat adoption across care settings.

Trexo Robotics was founded in July 2016 and has recorded four funding events: a 2017 pre-seed round, seed rounds in 2019 and 2021, and a grant dated June 13, 2024. Y Combinator is named as lead investor for the 2019 round, while Geekdom Fund and Techstars are listed for the pre-seed round. The company’s trajectory has since included a progression of products for home and clinical use, followed by a September 2026 launch of Trexo Theo with U.S. clearance for home use. Clinical adoption at McMaster Children’s Hospital in January 2026 and partnerships with pediatric physiotherapy providers and community organizations during 2025 offer evidence of efforts to expand access and use. The employee range remains listed at 1–10, and hiring information is nonspecific, so there is little basis to quantify organizational growth.